ArticleBritish journal of haematology2026

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.

Benjamin J Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.